High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients
about
DNA repair targeted therapy: The past or future of cancer treatment?MET inhibitors in combination with other therapies in non-small cell lung cancerProteasome inhibitors block DNA repair and radiosensitize non-small cell lung cancerElevated expression of Rad51 is correlated with decreased survival in resectable esophageal squamous cell carcinomaOverexpression of RAD51 occurs in aggressive prostatic cancerOnline survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancerMicroRNAs Used in Combination with Anti-Cancer Treatments Can Enhance Therapy EfficacyContributions of the RAD51 N-terminal domain to BRCA2-RAD51 interaction.Gene expression profiling reveals activation of the FA/BRCA pathway in advanced squamous cervical cancer with intrinsic resistance and therapy failurePhase 1B study of amuvatinib in combination with five standard cancer therapies in adults with advanced solid tumors.The RAD51-stimulatory compound RS-1 can exploit the RAD51 overexpression that exists in cancer cells and tumors.Rad51 supports triple negative breast cancer metastasis.Regulation of Rad51 promoter.Berberine radiosensitizes human esophageal cancer cells by downregulating homologous recombination repair protein RAD51RI-1: a chemical inhibitor of RAD51 that disrupts homologous recombination in human cellsRad51 inhibition is an effective means of targeting DNA repair in glioma models and CD133+ tumor-derived cellsPolymorphisms of homologous recombination genes and clinical outcomes of non-small cell lung cancer patients treated with definitive radiotherapy.RAD54 family translocases counter genotoxic effects of RAD51 in human tumor cells.Rad51 promoter-targeted gene therapy is effective for in vivo visualization and treatment of cancer.Treatment Outcome and Prognostic Molecular Markers of Supratentorial Primitive Neuroectodermal Tumors.Rapamycin-induced autophagy sensitizes A549 cells to radiation associated with DNA damage repair inhibition.Rad51 Expression in Nasopharyngeal Carcinoma and Its Association with Tumor Reduction: A Preliminary Study in Indonesia.Overexpression of Rad51 Predicts Poor Prognosis in Colorectal Cancer: Our Experience with 54 Patients.High RAD54B expression: an independent predictor of postoperative distant recurrence in colorectal cancer patientsRad51 in regulating the radiosensitivity of non-small cell lung cancer with different epidermal growth factor receptor mutation status.Association between Genetic Variants in DNA Double-Strand Break Repair Pathways and Risk of Radiation Therapy-Induced Pneumonitis and Esophagitis in Non-Small Cell Lung CancerFoxM1 inhibition sensitizes resistant glioblastoma cells to temozolomide by downregulating the expression of DNA-repair gene Rad51.Use of the Rad51 promoter for targeted anti-cancer therapyDysfunctional homologous recombination mediates genomic instability and progression in myeloma.Holliday junction trap shows how cells use recombination and a junction-guardian role of RecQ helicase.Rad51 expression is a useful predictive factor for the efficacy of neoadjuvant chemoradiotherapy in squamous cell carcinoma of the esophagus.Expression of PH Domain Leucine-rich Repeat Protein Phosphatase, Forkhead Homeobox Type O 3a and RAD51, and their Relationships with Clinicopathologic Features and Prognosis in Ovarian Serous Adenocarcinoma.DNA repair and cytotoxic drugs: the potential role of RAD51 in clinical outcome of non-small-cell lung cancer patients.DNA double-strand break repair as determinant of cellular radiosensitivity to killing and target in radiation therapy.Targeting homologous recombination-mediated DNA repair in cancer.A phase I, first-in-human dose-escalation study of amuvatinib, a multi-targeted tyrosine kinase inhibitor, in patients with advanced solid tumors.Personalised Medicine: Genome Maintenance Lessons Learned from Studies in Yeast as a Model Organism.RAD51 as a potential surrogate marker for DNA repair capacity in solid malignancies.Synthesis, molecular modeling, and biological evaluation of novel RAD51 inhibitors.ER stress suppresses DNA double-strand break repair and sensitizes tumor cells to ionizing radiation by stimulating proteasomal degradation of Rad51.
P2860
Q26768679-0CD7E653-CD01-44EA-91C4-7A9ACAF48A46Q26823203-1D776DD2-34D4-44E5-8CE0-A8F75DC27690Q27307731-30E9A6A0-3A26-4703-BC06-86FD7D70F436Q28242915-5BBD8B26-CD07-4A79-B2BC-AEE1F8153959Q28267299-3AF93C5E-74C0-4346-B0E0-C26AE380AF11Q28393146-D7341F3E-15E6-4E5C-9E15-6A38767E900FQ28829013-B9FD92DE-5605-4057-88D1-6FA82244A25CQ30551528-920B7FC9-9E32-4864-8D09-BC5D372ADD8AQ30578079-6D3C0722-4A59-4B05-B848-A8F8E3D6F5DCQ33415437-E13F939E-2372-46D1-8FF5-032ECDBACBB5Q33838509-D4507130-BC21-4CB2-8FF3-3C336B23CBB3Q33917622-16B2F4D1-68CA-458E-8057-5A46F205EC15Q33952859-045B8205-5F1E-4FE2-96ED-038FF8202022Q33999614-556D0400-0113-41E5-81BC-FD4FF0E750D1Q34273832-3DC229A0-7A62-41F4-A818-38BC73EA0D62Q34977354-E4637523-5202-4682-81F7-2867B01149CAQ35007346-0589B2D9-4E1C-4B84-A28C-A163FCFDA7D9Q35237084-ED897308-AEFC-444C-8525-F1FDFF0C350BQ35750271-E479F6AE-91EF-4FAE-B7FF-B90C7920CCCDQ35988515-02740970-7DFE-4FBC-A73D-F050CFB2B0DCQ36069410-72930F64-D76E-4953-AACC-DC1C90C77CE9Q36097164-C9BC1111-6AAE-4507-9B6D-67B68D3E9E77Q36252535-6B849FF3-DF9E-4883-929B-CDD21BA4B598Q36356237-1A22AF69-1C79-487B-A2C7-D294E8FA371FQ36477745-893E476A-71C4-4293-9668-3D066AD0550CQ36638191-7AD2CB93-00BC-42D4-AA4C-DD188FD76B38Q36803405-668225D4-5091-4410-8080-8408968CED84Q37081622-F54B3F9D-2A8C-4330-94B5-E308DA5ECD76Q37119930-938DD5AB-1A10-4324-952F-85C4BE897D69Q37574376-E69F0DB5-D37B-4B1A-BFD9-860271C5D2A5Q37594158-F63C292B-EAB6-443F-9B93-E07BA49247BCQ37640950-D677414B-D297-44AC-AF13-5AB3C5B5B927Q38097536-187DF19A-491B-42AB-B3E6-F22D1C766AC4Q38106985-F72ACA42-7D70-4F16-A8F5-DBD3353A178BQ38184667-459567CC-03DF-4782-9E0F-0948A6405904Q38460859-2379F651-1CBE-4F14-B284-44AE46861ADCQ38608688-BA9712FB-06CE-4278-B69D-D890EBBA0D58Q38801052-9C623A29-346C-490D-A309-18276C902735Q38887164-5EF61CAA-65F7-47EF-A66E-F41AF00579A5Q39097758-10DB72EE-C7F7-4B6A-A069-0BA6DA714C69
P2860
High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
High-level expression of Rad51 ...... mall-cell lung cancer patients
@ast
High-level expression of Rad51 ...... mall-cell lung cancer patients
@en
High-level expression of Rad51 ...... mall-cell lung cancer patients
@nl
type
label
High-level expression of Rad51 ...... mall-cell lung cancer patients
@ast
High-level expression of Rad51 ...... mall-cell lung cancer patients
@en
High-level expression of Rad51 ...... mall-cell lung cancer patients
@nl
prefLabel
High-level expression of Rad51 ...... mall-cell lung cancer patients
@ast
High-level expression of Rad51 ...... mall-cell lung cancer patients
@en
High-level expression of Rad51 ...... mall-cell lung cancer patients
@nl
P2093
P2860
P3181
P356
P1476
High-level expression of Rad51 ...... mall-cell lung cancer patients
@en
P2093
H-C Kolberg
H-W Stuerzbecher
P2860
P2888
P304
P3181
P356
10.1038/SJ.BJC.6602665
P407
P577
2005-07-01T00:00:00Z
P5875
P6179
1052410859